Mechanism of drug resistance in relation to site of metastasis: Meta-analyses of randomized controlled trials in advanced breast cancer according to anticancer strategy-Reference-Cited by-同舟云学术

Mechanism of drug resistance in relation to site of metastasis: Meta-analyses of randomized controlled trials in advanced breast cancer according to anticancer strategy

Published:2016-11 Issue: Volume:50 Page:168-174
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Niraula Saroj,Ocana Alberto

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference30 articles.

1. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma;Nielsen;Clin Cancer Res,2004

2. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications;Sorlie;Proc Natl Acad Sci USA,2001

3. Identifying breast cancer druggable oncogenic alterations: lessons learned and future targeted options;Ocana;Clin Cancer Res,2008

4. Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer;Swain;N Engl J Med,2015

5. Trastuzumab emtansine for HER2-positive advanced breast cancer;Verma;N Engl J Med,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isolation of potassium salt of oxadiazole-2-thione and in vitro anticancer activities of its Cu(ii) and Zn(ii) complexes against MDA-MB-231 human breast carcinoma cells;Dalton Transactions;2023

2. Is antibody-drug conjugate a rising star for clinical treatment of solid tumors? A systematic review and meta-analysis;Critical Reviews in Oncology/Hematology;2022-09

3. Comparative review of pharmacological therapies in individuals with HER2-positive advanced breast cancer with focus on hormone receptor subgroups;Frontiers in Oncology;2022-08-18

4. A pH-responsive complex based on supramolecular organic framework for drug-resistant breast cancer therapy;Drug Delivery;2021-12-30

5. A pH-responsive complex based on supramolecular organic framework for drug-resistant breast cancer therapy;Drug Delivery;2021-12-24